Endo International plc subsidiary Par Pharmaceutical has released mycophenolate mofetil hydrochloride as an injection in the United States after the Food and Drug Administration gave its approval of Endo’s Abbreviated New Drug Application. Read More »
Pfizer will expand its Advancing Science through Pfizer Investigator Research Exchange program next year. Read More »
Pfizer and its partner Avillion LLP have announced the results from the BFORE clinical study. Read More »
Sandoz's generic version of Latisse, bimatoprost ophthalmic solution, 0.03 percent, is now available in the United States. Read More »
ViiV Healthcare CEO Dr. Dominique Limet will relinquish his title and step down in March. Read More »
Baxter International Inc. has once again earned the highest possible score of 100 percent on the 2017 Corporate Equality Index, which is produced by the Human Rights Campaign Foundation. Read More »
Baxter International Inc. recently announced the recipients of its seventh annual Leadership Excellence Awards in Pharmacy at the American Society of Health-System Pharmacists 2016 Midyear Meeting. Read More »
Endo International and BioDelivery Sciences International (BDSI) have agreed to return the BELBUCA buccal film product to BDSI. Read More »
Merck Research Laboratories President Dr. Roger Perlmutter participated in the Citi 2016 Global Healthcare Conference Wednesday in New York. Read More »
Kite Pharma recently presented the results of its ZUMA-1 clinical trial involving axicabtagene ciloleucel (KTE-C19) at the American Society of Hematology (ASH) 58th Annual Meeting. Read More »
Theravance Biopharma's velusetrag (TD-5108) has been granted Fast Track designation by the U.S. Food and Drug Administration. Read More »
Voluntis has received FDA 510(k) clearance for Insulia, which also received the CE Mark for the treatment of Type 2 diabetes in adult patients that have had previous basal insulin treatments. Read More »
CTI BioPharma Corp.'s data from its PERSIST-2 Phase 3 clinical study was presented as a late-breaking oral session at the 58th American Society of Hematology Annual Meeting, which was held in San Diego Dec. 3-6. Read More »
The CVS Health Institute and the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response recently released research showing that automated notifications sent out by pharmacies are helping patients with chronic conditions remember to refill their medications before forecast natural disasters hit. Read More »
As National Influenza Vaccination Week runs through Saturday, CVS Pharmacy is reminding families across the U.S. that it is not too late to get their flu shots. Read More »
Rite Aid has announced that their customers will be able to save $5 on flu shots during National Influenza Vaccination Week in support of the cause. Read More »
Remedy Pharmaceuticals has named David Epstein a special adviser to the Board of Directors. Read More »
Amgen presented data from its Phase 3 TOWER study at the 58th Annual Meeting and Exposition of the American Society of Hematology this week in San Diego. Read More »
OptumRx and CVS Pharmacy say their collaboration that will provide improved health outcomes that are cost-efficient for consumers and clients while giving them more suitable choices. Read More »
Eisai Inc. has released the final results of its Phase 3 rufinamide study, an open-label, two-year investigation. Read More »
Alerts Sign-up
